Primary Record
Setanaxib
- In stock
- 8,157 g
- Purity
- 98.3 %
- CAS
- 1218942-37-0
Compound Identifiers & Properties
- CAS
- 1218942-37-0
- PubChem CID
- 58496428
- SMILES
- CN1C(=O)C=C2C(=C1C3=CC(=CC=C3)N(C)C)C(=O)N(N2)C4=CC=CC=C4Cl
- Canonical SMILES
- CN(C)c1cccc(-c2c3c(=O)n(-c4ccccc4Cl)[nH]c3cc(=O)n2C)c1
Names & Synonyms
- Setanaxib
- GKT137831
- 1218942-37-0
- GKT-137831
- setanaxibum
- GKT-831
- 2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione
- Setanaxib [WHO-DD]
- KRIVQRIKDFLR-NH2
- SETANAXIB [INN]
- RefChem:182612
- GKT831
- C21H19ClN4O2
- D04XVU
- MFCD27923122
- UNII-45II35329V
- GKT137831(Setanaxib)?
- Setanaxib (GKT137831)
- DTXSID30153432
- GKT-01
- GTPL9932
- orb1301074
- SCHEMBL1302603
- 45II35329V
- CHEMBL4303187
- DTXCID7075923
- GKT 137831
- SCHEMBL29362127
- SCHEMBL29375704
- KS-00000RLK
- AOB5773
- EX-A577
- GKT 831
- RGYQPQARIQKJKH-UHFFFAOYSA-N
- GLXC-06001
- BCP14159
- BDBM50628591
- EBC-44352
- s7171
- ZINC95670835
- AKOS022176138
- CCG-268595
- CS-3290
- SB19230
- NCGC00378460-05
- NCGC00378460-08
- NCGC00378460-09
- AC-33132
- AK134876
- AS-74753
- BC600624
- CID:58496428
- DA-33605
- FG137680
- HY-12298
- SID:318495247
- AJ-133482
- ST2409276
- 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6-dione
- 4CH-016131
- FT-0700121
- X3563
- 2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo(4,3-c)pyridine-3,6(2H,5H)-dione
- J3.294.932K
- A14433
- A891302
- C576694
- EN300-20043919
- 1H-Pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione, 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-
- BRD-K79710622-001-01-1
- BRD-K79710622-001-02-9
- Q27258840
- 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H,2H,3H,5H,6H-pyrazolo[4,3-c]pyridine-3,6-dione
- 2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1,2-dihydro-3H-pyrazolo[4,3-c]pyridine-3,6(5H)-dione
- 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1h-pyrazolo[4,3-c]pyridine-3,6(2h,5h)-dione
- NADPH oxidase inhibitor (oral, renal cancer/ idiopathic pulmonary fibrosis), GenKyoTex
- 1218951-51-9
- 1H-PYRAZOLO(4,3-C)PYRIDINE-3,6(2H,5H)-DIONE, 2-(2-CHLOROPHENYL)-4-(3-(DIMETHYLAMINO)PHENYL)-5-METHYL-
- 2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo(4,3-c)pyridine-3,6-dione
- 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-6-hydroxy-5-methylpyrazolo[4,3-c]pyridin-3-one
- 942-974-8